reports
- GlobalData Healthcare Department
Tobira Therapeutics Inc (TBRA) - Pharmaceuticals & Healthcare - Deals ...
Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Evogliptin (EVO). The company’s lead product candidate, cenicriviroc, is a proprietary immunomodulator which is used to treat diseases such as HIV-1, and others. Evogliptin is an orally bioavailable,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.